Pulmonary thromboembolism due to severe hyperhomocysteinemia associated with a methyltetrahydrofolate reductase mutation.
Kyung Hoon
KH
Cho
Myung Ho
MH
Jeong
Doo Sun
DS
Sim
Young Joon
YJ
Hong
Ju Han
JH
Kim
Youngkeun
Y
Ahn
Jung Chaee
JC
Kang
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D004252:DNA Mutational Analysis; D004452:Echocardiography; D020022:Genetic Predisposition to Disease; D006720:Homozygote; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D009154:Mutation; D010641:Phenotype; D011655:Pulmonary Embolism / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012720:Severity of Illness Index; D015912:Thrombolytic Therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014815:Vitamins / Q000627:therapeutic use
D000925:Anticoagulants; D014815:Vitamins; C573423:MTHFR protein, human; D042965:Methylenetetrahydrofolate Reductase (NADPH2)
Folate; Hyperhomocysteinemia; Pulmonary embolism